Brief: Amphastar Pharmaceuticals Q1 EPS USD 0.14
07/05/2026 21:05
May 07 (Reuters) - Amphastar Pharmaceuticals Q1 net income USD 6.42 million. Q1 revenue USD 171.171 million vs. IBES estimate USD 173.4 million Q1 adjusted net income USD 19.478 million vs. IBES estimate USD 33.2 million Q1 adjusted EPS USD 0.42 vs. IBES estimate USD 0.7
Recent news on Amphastar Pharmaceuticals
See all newsAmphastar Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Amphastar Pharmaceuticals Q2 EPS USD 0.67
U.S. STOCKS ON THE MOVE-RBB Bancorp, Roblox, Open Lending
U.S. STOCKS ON THE MOVE-Amkor Technology, Dynatrace, Corvex
Amphastar rises after FDA approves new over-the-counter overdose spray